Chronic Rhinosinusitis with Nasal Polyps Market Size and Scope 2025 to 2034
Global Chronic Rhinosinusitis with Nasal Polyps Market Size is valued at USD 1.8 Bn in 2024 and is predicted to reach USD 3.4 Bn by the year 2034 at a 6.6% CAGR during the forecast period for 2025 to 2034. Chronic Rhinosinusitis with Nasal Polyps Market Size, Share & Trends Analysis Report By Treatment Type (Pharmacological Treatments (Corticosteroids, Antibiotics, Biologic Drugs, Antihistamines, Leukotriene Modifiers), Surgical Intervention...
Report ID: 3069 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 180
RAS-Targeting Drugs for Precision Oncology Market Size, Share and Key Players Analysis 2025 to 2034
Global RAS-Targeting Drugs for Precision Oncology Market Size is predicted to grow with a 11.9% CAGR during the forecast period for 2025 to 2034. RAS-Targeting Drugs for Precision Oncology Market Size, Share & Trends Analysis Distribution by Drug Type (Small Molecule Inhibitors, Biologics, RNA-Based Therapies, Combination Therapies), Target Mutation (KRAS G12C, KRAS G12D, KRAS G12V, G12R, G12S, G12A, HRAS and NRAS, Pan-RAS), Indication ...
Report ID: 3074 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 170
T-cell Engagers Market Size, Share and Trends Analysis 2025 to 2034
Global T-cell Engagers Market Size is predicted to grow at a 31.6% CAGR during the forecast period for 2025 to 2034. T-cell Engagers Market, Share & Trends Analysis Report, By Application (Therapeutic, Diagnostic/Prognostic, Research), By Technology Type (Bispecific T-cell Engagers (BiTEs), Other Bispecific Antibodies, Next-Gen Engagers), By Cancer Type (Hematologic Cancers, Solid Tumors), By End-User (Hospitals, Specialty Clinics/Outpatient...
Report ID: 3002 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 180
Human Native Antigens and Recombinant Antigens Market Size and Revenue Impact Study 2025 to 2034
Global Human Native Antigens and Recombinant Antigens Market Size was valued at USD 185.8 Mn in 2024 and is predicted to reach USD 368.0 Mn by 2034 at a 7.3% CAGR during the forecast period for 2025 to 2034. Human Native Antigens and Recombinant Antigens Market Size, Share & Trends Analysis Report, By Type (Human Native Antigens & Recombinant Antigens), By Application (Scientific Research, Immunodiagnostic Test, Clinical Biochemistry, &n...
Report ID: 3038 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 170
Precision Diagnostics & Medicine Market Forecast with Size and Share Analysis 2025 to 2034
Global Precision Diagnostics & Medicine Market Size was valued at USD 138.4 Bn in 2024 and is predicted to reach USD 425.9 Bn by 2034 at a 12.3% CAGR during the forecast period for 2025 to 2034. Precision Diagnostics & Medicine Market Size, Share & Trends Analysis Report, By Type (Genetic, DTC and Others), By Indication (Diagnostic and Medicine), By End-user, By Product, By Region, Forecasts, 2025 to 2034 The rapidly developing di...
Report ID: 3040 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 180
Medical Records Retrieval Market Research Report with Forecast 2025 to 2034
Global Medical Records Retrieval Market Size is valued at USD 1.1 Bn in 2024 and is predicted to reach USD 2.8 Bn by the year 2034 at a 10.1% CAGR during the forecast period for 2025 to 2034. Medical Records Retrieval Market Size, Share & Trends Analysis Report By Type (Electronic Medical Record, Electronic Health Record, Others), By Application (Doctors, Legal Teams, Insurance Companies, Others), by Region, And by Segment Forecasts, 2...
Report ID: 3042 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 170
Visual Dispensing Machine Market Size, Growth and Trends Report 2025 to 2034
Global Visual Dispensing Machine Market Size is valued at USD 1.3 Bn in 2024 and is predicted to reach USD 3.4 Bn by the year 2034 at a 10.2% CAGR during the forecast period for 2025 to 2034. Visual Dispensing Machine Market Size, Share & Trends Analysis Report by type (Automatic, Semi-Automatic, Manual), by application (Pharmaceuticals, Electronics, Food and Beverage, Cosmetics, Others), and by end-user (Healthcare, Retail, Manufacturing, L...
Report ID: 3045 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 180
Stem Cell Therapy for Respiratory Disorders Market Size, Share and Growth Analysis 2025 to 2034
Global Stem Cell Therapy for Respiratory Disorders Market Size is estimated to grow with a 17% CAGR during the forecast period for 2025 to 2034. Stem Cell Therapy for Respiratory Disorders Market Size, Share & Trends Analysis Distribution By Indications (Acute Respiratory Distress Syndrome, Bronchopulmonary Dysplasia, Idiopathic Pulmonary Fibrosis, Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension), Cell Type (Mese...
Report ID: 3332 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 180
Lipid Nanoparticles (LNPs) CDMO Market Size, Share and Growth Analysis 2025 to 2034
Global Lipid Nanoparticles (LNPs) CDMO Market Size is valued at USD 205.4 Mn in 2024 and is predicted to reach USD 803.6 Mn by the year 2034 at a 14.8% CAGR during the forecast period for 2025-2034. Lipid Nanoparticles (LNPs) CDMO Market Size, Share & Trends Analysis Report By Product (mRNA , Plasmid DNA (pDNA), siRNA, saRNA, microRNA, and Others), Scale Of Operation (Preclinical, Clinical , and Commercial), End-Users, By Region, A...
Report ID: 1432 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 190
Radiopharmaceutical CDMO/CMO Services Market Size, Share and Forecast 2025 to 2034
Global Radiopharmaceutical CDMO/CMO Services Market Size is valued at USD 2.9 Billion in 2024 and is predicted to reach USD 7.0 Billion by the year 2034 at a 9.2% CAGR during the forecast period for 2025 to 2034. Radiopharmaceutical CDMO/CMO Services Market Size, Share & Trends Analysis Distribution (Application (Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals), Type of Radioisotope (Technetium-99m, Fluorine-18, Leutetiu...
Report ID: 2472 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 180
Pharmaceuticals